Kymera Therapeutics, Inc.
KYMR
$29.97
-$0.05-0.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.24% | -11.13% | 7.85% | -2.03% | 38.86% |
| Total Receivables | 2,011.93% | -28.09% | -22.71% | -16.06% | -89.18% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.49% | 18.07% | 26.75% | -6.33% | 25.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.83% | -10.28% | 8.24% | -2.20% | 32.55% |
|
|
|||||
| Total Current Assets | -1.83% | -10.28% | 8.24% | -2.20% | 32.55% |
| Net Property, Plant & Equipment | -2.00% | -1.46% | -1.13% | 1.80% | -2.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.77% | 33.91% | -25.19% | -2.68% | 0.18% |
| Total Assets | -6.11% | -5.49% | 25.28% | -4.86% | 50.80% |
|
|
|||||
| Total Accounts Payable | 71.36% | -7.78% | -0.25% | -4.43% | -3.72% |
| Total Accrued Expenses | -33.70% | 31.42% | 11.56% | 48.65% | -52.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.98% | 2.03% | 3.50% | 25.54% | 55.87% |
| Total Finance Division Other Current Liabilities | -10.36% | -33.20% | 6.28% | -17.07% | -38.98% |
| Total Other Current Liabilities | -10.36% | -33.20% | 6.28% | -17.07% | -38.98% |
| Total Current Liabilities | -12.95% | 1.86% | 7.06% | 10.70% | -34.49% |
|
|
|||||
| Total Current Liabilities | -12.95% | 1.86% | 7.06% | 10.70% | -34.49% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.09% | -0.97% | -0.51% | -1.77% | -1.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -86.59% | 41.82% |
| Total Liabilities | -7.26% | 0.36% | 0.58% | -10.16% | -13.13% |
|
|
|||||
| Common Stock & APIC | 0.93% | 1.07% | 20.37% | 1.25% | 39.51% |
| Retained Earnings | -8.69% | -10.35% | -10.06% | -7.26% | -9.15% |
| Treasury Stock & Other | 96.09% | -176.90% | 192.00% | -18.12% | -221.92% |
| Total Common Equity | -5.91% | -6.42% | 30.37% | -3.70% | 80.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.91% | -6.42% | 30.37% | -3.70% | 80.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.91% | -6.42% | 30.37% | -3.70% | 80.06% |
|
|
|||||